EMJ GOLD: Pharma news, views and analysis

This week, it's time to look back at the past month in pharma, examining the industry response to coronavirus, potential blockbuster drugs of 2020 and some innovative disease awareness campaigns that score high on creativity.  

Spencer is joined by the Executive Chairman of Brandon Medical, Graeme Hall, who reveals how the medical device industry is evolving and deconstructs the impact of 4K and smart operating theatres on the surgical process.

Sen is joined by a special guest on this week's podcast: Claudia Adreani, Business Head of Customer Excellence at Boehringer Ingelheim. Amongst a plethora of topics, they discuss the evolving world of marketing in pharma and Claudia's gymnastics pedigree!

Spencer is joined by eyeforpharma Chairman Paul Simms to discuss the upcoming eyeforpharma Barcelona 2020 event, as well as the importance of pharma finding and communicating their purpose to the public.

The new year has seen the pharma industry's involvement in a number of issues of global significance. And this week, Sen takes us through initiatives pharma companies have begun in January to combat the coronavirus outbreak and climate change.

Sen chats to James, co-founder of social media consultancy, Social Tree Global. They discuss the SMIP event he hosted in November and explore why pharma should overcome their social media fears to create meaningful relationships with HCPs and patients.

Isabel is joined again by Michaila to discuss her recent GOLD article, 'Marketing Forecast: Cloudy with a Chance of AI', which looks at the potential of AI to help pharma marketers streamline budgets and target with better accuracy...

Spencer is joined by Kris Sterkens, Company Group Chairman (Europe, Middle East and Africa) of Janssen and they discuss a range of topics including the evolving sales landscape, learning from tech start-ups and patient-centric drug development.

Sen casts some predictions for the coming year, looking at how the industry may respond to the rise of medicinal cannabis, as well as patient demand for easier access to clinical trials.

Sen reflects on the year 2019 and all the exciting news, challenges and trends that have been taking place in the pharmaceutical industry.

Sen and Isabel discuss how the pharmaceutical industry can refresh their traditional sales and marketing models, plus reveal how storytelling can be the key to engaging colleagues with radical change.

We chat to CEO of Trifolium Consulting and GP of over 30 years, Nigel Guest. He shares his passion for developing medical devices, reflects on the evolution of the NHS and considers the changing role of the GP in an increasingly digital world.

Isabel and Michaila reflect on an article featured in GOLD 07 that considers the importance of mental health and pharma's internal duty of care to employees.

Sen takes us through a positive month of corporate responsibility in pharma, highlighting the bold steps the industry is taking to improve lives on both a global and local scale.

This week, the EMG-Health Podcast features Jonathan interviewing Montel Williams. They touch upon Montel's military and entertainment career and discuss the MS diagnosis that led to his advocacy of cannabis as a legitimate means of therapeutic treatment.

Sen and Kirstie offer a preview into what our readers can expect from the November issue of GOLD magazine. They reveal the identity of our Catalyst interviewee and discuss some of the exciting topics, including AI and the power of happiness...

This week, EMG's COO, Dan Scott welcomes Eric Bouilloux, Chief of Staff, Global Medical Affairs, Ipsen to the EMG office. Eric discusses his career path to his current position, and also shares his views on the evolution of medical affairs.

This week, Sen takes us through a number of important announcements regarding changes to top executive positions in pharma during October. She also considers the impact these could have for the industry in the near future.

Two of the GOLD editorial team, Isabel and Michaila, explore the long-awaited reform of the European patent system: Unitary Patent. What does it mean for pharma? And what has led to its delay?

Kirstie and Michaila discuss the eyeforpharma Patient Summit and Marketing and Customer Innovation conference that took place in London on 15th and 16th October 2019.

In this episode, Michaila and Kirstie look at exciting innovations that are enabling disabled people to live independently and discuss the potential role pharma could play in this area in the future.

Debuting on this week's EMG Podcast is Isabel and Michaila from the GOLD editorial team. Together they discuss the rise and influence of the podcast and why pharma should be embracing the medium.

Sen takes us through some particularly eye-catching stories from the pharma industry in September. This includes developments in emerging areas such as medicinal marijuana, digital therapeutics, and AI technology.

This week, we hear the thoughts of Andrea Palmer, President of Publicis Health Media, on a range of topics, including how the pharma industry can fulfil evolving consumer expectations, plus her personal ambitions and career highlights to date.

This week, eyeforpharma Chairman Paul Simms visits the EMG offices to chat to Spencer about the upcoming eyeforpharma patient and marketing conferences in London in October, as well as his perspective on recent trends in the pharma industry.